Department of Internal Medicine, University of California, Riverside, CA, Unites States.
Department of Pulmonary and Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH, Unites States.
Resuscitation. 2023 Aug;189:109890. doi: 10.1016/j.resuscitation.2023.109890. Epub 2023 Jun 28.
To assess whether there were differences in resuscitation efforts and outcomes for medical intensive care unit (MICU) in-hospital cardiac arrest (IHCA) during the COVID-19 pandemic when compared to pre-pandemic.
Comparing COVID-19 MICU-IHCA patients (03/2020 to 10/2020) to non-COVID-19 MICU IHCA (01/2014 to 12/2018) at Clevleand Clinic Health System (CCHS) of NE Ohio. Propensity score matching analysis (PSMA) was used to create comparable groups.
There were a total of 516 patients, 51 in COVID-19 MICU IHCA cohort and 465 in the non-COVID-19 MICU IHCA cohort. The mean (SD) age of the study population was 60.9 (16) years and 56% were males. In 92.1% (n = 475) patients, initial arrest rhythm was non-shockable. At the time of ICU admission, compared to the non-COVID-19 MICU-IHCA cohort, the COVID-19 MICU IHCA cohort had a lower mean APACHE III score (70 [32.9] vs 101.3 [39.6], P = <0.01). The COVID-19 cohort had a higher rate of survival to hospital discharge (12 [23.5%] vs 59 [12.7%], P = 0.03). Upon PSMA, the algorithm selected 40 COVID-19 patients and 200 non-COVID-19 patients. Imbalances in baseline characteristics, comorbidities, and APACHE III were well-balanced after matching. Survival rate after matching became non-significant; (10 [25%] vs 42 [21%], P = 0.67). Further, there were no significant differences in ICU or hospital length-of-stay or neurological outcomes at discharge for survivors in the two matched cohorts.
It is imperative that COVID-19 patients receive unbiased and unrestricted resuscitation measures, without any discouragement.
评估与大流行前相比,在 COVID-19 大流行期间,医疗重症监护病房(MICU)院内心搏骤停(IHCA)的复苏努力和结果是否存在差异。
在克利夫兰诊所卫生系统(CCHS)俄亥俄州东北部比较 COVID-19 MICU-IHCA 患者(2020 年 3 月至 2020 年 10 月)与非 COVID-19 MICU IHCA 患者(2014 年 1 月至 2018 年 12 月)。使用倾向评分匹配分析(PSMA)创建可比组。
共有 516 名患者,COVID-19 MICU IHCA 队列 51 名,非 COVID-19 MICU IHCA 队列 465 名。研究人群的平均(SD)年龄为 60.9(16)岁,56%为男性。在 92.1%(n=475)的患者中,初始骤停节律是非可除颤的。与非 COVID-19 MICU-IHCA 队列相比,在 ICU 入院时,COVID-19 MICU IHCA 队列的平均 APACHE III 评分较低(70 [32.9] 与 101.3 [39.6],P<0.01)。COVID-19 队列的存活率更高,达到出院(12 [23.5%] 与 59 [12.7%],P=0.03)。经过 PSMA,算法选择了 40 名 COVID-19 患者和 200 名非 COVID-19 患者。匹配后,基线特征、合并症和 APACHE III 的不平衡得到了很好的平衡。匹配后生存率变得不显著;(10 [25%] 与 42 [21%],P=0.67)。此外,在两个匹配队列中,幸存者的 ICU 或住院时间或出院时的神经结果没有差异。
至关重要的是,COVID-19 患者应接受无偏见和不受限制的复苏措施,而不应有任何劝阻。